HPLC–high-Resolution Mass Spectrometry with Polarity Switching for Increasing Throughput of Human in vitro Cocktail Drug–Drug Interaction Assay
Authors:
- 11 May 2018
- journal article
- research article
- Published by Taylor & Francis in Bioanalysis
- Vol. 10 (9) , 659-672
Abstract
Aim: Evaluation of HPLC–high-resolution mass spectrometry (HPLC–HRMS) full scan with polarity switching for increasing throughput of human in vitro cocktail drug–drug interaction assay. Materials & methods: Microsomal incubates were analyzed using a high resolution and high mass accuracy Q-Exactive mass spectrometer to collect integrated qualitative and quantitative (Qual/Quant) data. Results: Within assay, positive-to-negative polarity switching HPLC–HRMS method allowed quantification of eight and two probe compounds in the positive and negative ionization modes, respectively, while monitoring for LOR and its metabolites. Conclusion: LOR-inhibited CYP2C19 and showed higher activity for CYP2D6, CYP2E1 and CYP3A4. Overall, LC–HRMS-based nontargeted full scan quantitation allowed to improve the throughput of the in vitro cocktail drug–drug interaction assay.Keywords
This publication has 29 references indexed in Scilit:
- Endogenous Probes for Drug Transporters: Balancing Vision With RealityClinical Pharmacology & Therapeutics, 2017
- Transporter‐Mediated Hepatic Uptake Plays an Important Role in the Pharmacokinetics and Drug–Drug Interactions of MontelukastClinical Pharmacology & Therapeutics, 2016
- Drug–Drug Interaction Studies: Regulatory Guidance and An Industry PerspectiveThe AAPS Journal, 2013
- Therapeutic Protein–Drug Interactions and Implications for Drug DevelopmentClinical Pharmacology & Therapeutics, 2010
- Drug interactions evaluation: An integrated part of risk assessment of therapeuticsToxicology and Applied Pharmacology, 2010
- Predicting Drug–Drug Interactions: An FDA PerspectiveThe AAPS Journal, 2009
- New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance ProcessThe Journal of Clinical Pharmacology, 2008
- Integrated Strategies for Drug Discovery Using Mass Spectrometry2005
- Can the pharmaceutical industry reduce attrition rates?Nature Reviews Drug Discovery, 2004
- Sense and Nonsense in the Prediction of Drug-Drug InteractionsCurrent Drug Metabolism, 2000